Skip to content

Outcome of root canal therapy and pulpotomy on permanent mature molars

Evaluation of full pulpotomy in cariously exposed mature permanent molar teeth with new calcium silicate cement : A Randomized Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220305054200N1
Enrollment
90
Registered
2022-04-25
Start date
2022-04-24
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Diseases of pulp and periapical tissues. Condition 2: Pulpitis. Diseases of pulp and periapical tissues Pulpitis

Interventions

Intervention 1: Control group: Root canal therapy. Intervention 2: Intervention group 1: Pulpotomy with new calcium silicate cement. Intervention 3: Intervention group 2: Pulpotomy with MTA.

Sponsors

Zahedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 50 Years

Inclusion criteria

Inclusion criteria: A vital molar tooth (confirmed with cold spray and electric pulp tester before treatment and visual inspection of pulpal hemorrhage after access cavity preparation) A history of pain indicating irreversible pulpitis (i.e. spontaneous localized/generalized pain, pain stimulated by hot and cold fluids that lasts after elimination of the stimulus and is reproducible with cold testing) Pulp exposure during caries removal when no sign of irreversible pulpitis is present Patients in the range of 12 to 50 years Patients who accept to attend for recalls Patients who approve and sign the written informed consent

Exclusion criteria

Exclusion criteria: Patients with systemic conditions that disturb tissue healing process (including diabetes, cancer, endocrine diseases, AIDS and consumption of corticosteroids) Patients with epinephrine intolerance Pregnant/nursing women Physically disabled or mentally retarded patients Patients with poor oral hygiene or those with periodontal diseases, where the long term preservation of the tooth may not be possible Immigrants such as those from Afghanistan, who are likely to leave the country during the subsequent two years Patients younger than 12 (for 1st molar treatment) and 15 (for 2nd molar treatment) and patients older than 50 Non-vital/partially necrotic teeth confirmed with primary examinations or diagnosed after access cavity preparation Teeth with pulpal inflammation spreading beyond the canal orifices, and continuous bleeding after placement of cotton pellet soaked in 2.5% sodium hypochlorite for a maximum of 10 minutes Teeth that are not appropriate candidates for class I and II (Occlusal, MO, DO, MOD) restoration and require complicated build-ups, crown lengthening or prosthetic crown Teeth with localized periodontal disease (i.e. probing depth more than?3 mm) where the tooth survival is not endangered but pulpal irritation and disturbed healing due to root exposure is likely Internal/external root resorption or pulp calcification detectable in periapical radiography Teeth with history of trauma Swelling of surrounding soft tissues Teeth with immature apices Presence of sinus tract

Design outcomes

Primary

MeasureTime frame
Sign and symptoms of pulpal inflammation/infection (spontaneous unstimulated pain). Timepoint: Six months after treatmentOne week and 6 months after intervention. Method of measurement: Clinical examination and VAS (visual analogue scale) questionnaire.;Sign and symptoms of pulpal inflammation (internal/external resorption). Timepoint: Six months after treatmentOne week and 6 months after intervention. Method of measurement: Periapical radiographs.;Sign and symptoms of periapical inflammation (pain on percussion and palpation). Timepoint: Six months after treatmentOne week and 6 months after intervention. Method of measurement: Clinical examination and VAS (visual analogue scale) questionnaire.;Sign and symptoms of periapical infection (pain, redness, swelling or formation of sinus tract). Timepoint: Six months after treatmentOne week and 6 months after intervention. Method of measurement: Clinical examination and VAS (visual analogue scale) questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarnaz Faramarzian

Zahedan University of Medical Sciences

farnazfaramarzian@gmail.com+98 54 3344 1814

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026